CJC-1295 is a long-acting synthetic analogue of GHRH featuring a Drug Affinity Complex (DAC) modification that extends its half-life. Widely used in GH secretion research.
About CJC-1295
CJC-1295 is a modified GHRH peptide with a lysine-biotin linker (DAC) that allows it to bind to albumin, significantly extending its circulating half-life compared to native GHRH. Used extensively in growth hormone axis research.
Research applications
Growth hormone axis and GHRH receptor studies
Long-acting GHRH analogue pharmacology
Metabolic and body composition research
Comparative GHRH analogue studies
Product name
CJC-1295
CAS number
863288-34-0
Purity
≥99.1% (HPLC verified)
Appearance
White to off-white lyophilized powder
Format
Lyophilized powder
Testing
HPLC, LC-MS, endotoxin
Accreditation
ISO/IEC 17025 third-party lab
Origin
GMP-certified synthesis facility
Storage guidelines
Lyophilized powder (unreconstituted)
Store at −20°C in original sealed vial, away from light and moisture
Stable for 24+ months under proper conditions
Allow vial to reach room temperature before opening to avoid condensation
After reconstitution
Store at −80°C; aliquot into single-use volumes to avoid freeze-thaw cycles
Use within 4–6 weeks of reconstitution when stored at −80°C
Specific lot stability data provided on your Certificate of Analysis.
Independent testing & verification
Every batch is tested by an independent ISO/IEC 17025-accredited laboratory before release — separate from our synthesis facility.
Tests performed
HPLC purity analysis — confirms ≥99.1% purity with full chromatogram